en

PRODUCT DETAIL

Lavekan

Code 1826D
MA number 70/0185/19-S
Product Form: cps mol 28x80 mg (blis.PVC/PVDC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 70 - ANXIOLYTICA
ATC:
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05B ANXIOLYTICS
N05BX Other anxiolytics
N05BX05 Lavandulae aetheroleum
Shelf life: 120
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product not subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 20.06.2019
Validity: 20.06.2024
PIL: PIL_Lavekan_02.2021.docx  
SPC: SPC_Lavekan_02.2021.docx  
Safety feature No
Data update: 01.07.2019
eu-flag.png sk-flag.png